• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型强效非甾体抗炎药醋氯芬酸的药理学

Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.

作者信息

Grau M, Guasch J, Montero J L, Felipe A, Carrasco E, Juliá S

机构信息

Department of Pharmacology and Toxicology, Prodesfarma Research Center, Barcelona, Spain.

出版信息

Arzneimittelforschung. 1991 Dec;41(12):1265-76.

PMID:1815528
Abstract

Aceclofenac (2-[(2,6-dichlorophenyl) amine]phenylacetoxyacetic acid; CAS 89796-99-6) is a new orally effective non-steroidal anti-inflammatory agent of the phenylacetic acid group which showed remarkable anti-inflammatory, analgesic, and antipyretic properties. Hence, aceclofenac possesses a potent inhibitory activity in several models of acute and chronic inflammation in rodents, and resembles indometacin and diclofenac in its pharmacodynamic profile, being superior to naproxen and phenylbutazone. In addition, aceclofenac was found to be highly active against sodium urate-induced synovitis in dogs and adjuvant-induced polyarthritis in rats, both prophylactically and therapeutically. The analgesic effect of aceclofenac on the pain elicited by chemical and mechanical stimuli was nearly equal to or slightly better than that of indometacin and diclofenac. Fever induced by brewer's yeast injection in rats was also markedly suppressed by aceclofenac. In contrast, the acute gastric ulcerogenic activity of aceclofenac was about 2, 4 and 7-fold lesser than that of naproxen, diclofenac, or indometacin, respectively. As a consequence of its high anti-inflammatory activity and lower potential for gastric damage aceclofenac exhibited the most favourable therapeutic ratio in comparison with indometacin, diclofenac, naproxen, and phenylbutazone. These data indicate that aceclofenac could be a potent anti-inflammatory and analgesic agent with a wide margin of safety in clinical practice.

摘要

醋氯芬酸(2-[(2,6-二氯苯基)氨基]苯乙酰氧基乙酸;CAS 89796-99-6)是一种新型口服有效的苯乙酸类非甾体抗炎药,具有显著的抗炎、镇痛和解热特性。因此,醋氯芬酸在多种啮齿动物急慢性炎症模型中具有强大的抑制活性,其药效学特征与吲哚美辛和双氯芬酸相似,优于萘普生和保泰松。此外,已发现醋氯芬酸在预防和治疗方面对犬尿酸钠诱导的滑膜炎和大鼠佐剂性多关节炎均具有高度活性。醋氯芬酸对化学和机械刺激引起的疼痛的镇痛作用几乎与吲哚美辛和双氯芬酸相当或略优。醋氯芬酸也能显著抑制大鼠注射啤酒酵母诱导的发热。相比之下,醋氯芬酸的急性致胃溃疡活性分别比萘普生、双氯芬酸或吲哚美辛低约2倍、4倍和7倍。由于其高抗炎活性和较低的胃损伤可能性,与吲哚美辛、双氯芬酸、萘普生和保泰松相比,醋氯芬酸表现出最有利的治疗比率。这些数据表明,醋氯芬酸在临床实践中可能是一种具有广泛安全范围的强效抗炎和镇痛药。

相似文献

1
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.新型强效非甾体抗炎药醋氯芬酸的药理学
Arzneimittelforschung. 1991 Dec;41(12):1265-76.
2
The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.2-(8-甲基-10,11-二氢-11-氧代二苯并[b,f]氧杂卓-2-基)丙酸(AD-1590)的药理学特征,一种具有强效解热活性的新型非甾体抗炎药。
Arzneimittelforschung. 1983;33(11):1555-69.
3
Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).一种新型非甾体抗炎药:2-(5-乙基吡啶-2-基)苯并咪唑(KB-1043)的药理学研究
Arzneimittelforschung. 1982;32(1):49-55.
4
Comparison of the anti-inflammatory effect and gastrointestinal tolerability of aceclofenac and diclofenac.醋氯芬酸与双氯芬酸抗炎作用及胃肠道耐受性的比较。
Arzneimittelforschung. 1996 Apr;46(4):398-400.
5
The pharmacological profile of aceclofenac, a new nonsteroidal antiinflammatory and analgesic drug.
Agents Actions Suppl. 1991;32:125-9. doi: 10.1007/978-3-0348-7405-2_17.
6
Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.新型非甾体抗炎药依托度酸的药理特性
Arzneimittelforschung. 1991 Mar;41(3):228-35.
7
Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.新型抗炎药N-(3-[3-(哌啶基甲基)苯氧基]丙基)-氨甲酰甲基硫代]乙基1-(对氯苯甲酰基)-5-甲氧基-2-甲基-3-吲哚乙酸酯的抗炎、镇痛和解热作用及胃肠道毒性
Arzneimittelforschung. 1992 Jul;42(7):954-8.
8
Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.新型抗炎药3-甲酰氨基-7-甲基磺酰氨基-6-苯氧基-4H-1-苯并吡喃-4-酮的药理学研究。首次通讯:抗炎、镇痛及其他相关性质。
Arzneimittelforschung. 1992 Jul;42(7):935-44.
9
Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.新型非甾体抗炎药屈昔康的药理特性
Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22.
10
The pharmacological properties of fenbufen. A review.联苯乙酸的药理特性。综述。
Arzneimittelforschung. 1980;30(4A):716-21.

引用本文的文献

1
Nano-Engineered Hybridized Polymeric Framework for Chronic Wound Management.用于慢性伤口管理的纳米工程杂化聚合物框架
AAPS PharmSciTech. 2025 May 16;26(5):134. doi: 10.1208/s12249-025-03124-5.
2
Safety and effectiveness of 4-week therapy with aceclofenac controlled release once a day.一天一次服用醋氯芬酸控释片 4 周的安全性和有效性。
Sci Rep. 2022 Oct 3;12(1):16519. doi: 10.1038/s41598-022-20633-6.
3
Efficacy and safety of short-term use of a pelubiprofen CR and aceclofenac in patients with symptomatic knee osteoarthritis: A double-blinded, randomized, multicenter, active drug comparative, parallel-group, phase IV, non-inferiority clinical trial.
短期使用培鲁布洛芬 CR 和双氯芬酸在症状性膝骨关节炎患者中的疗效和安全性:一项双盲、随机、多中心、阳性药物对照、平行组、四期、非劣效性临床试验。
PLoS One. 2020 Sep 29;15(9):e0238024. doi: 10.1371/journal.pone.0238024. eCollection 2020.
4
Pharmacokinetics of a new once-daily controlled-release formulation of aceclofenac in Korean healthy subjects compared with immediate-release aceclofenac and the effect of food: a randomized, open-label, three-period, crossover, single-centre study.在韩国健康受试者中比较新型每日一次控释制剂醋氯芬酸与普通制剂醋氯芬酸及食物影响的药代动力学:一项随机、开放标签、三周期、交叉、单中心研究。
Clin Drug Investig. 2012 Feb 1;32(2):111-9. doi: 10.2165/11596530-000000000-00000.
5
Development and evaluation of pharmacosomes of aceclofenac.醋氯芬酸药物脂质体的研制与评价
Indian J Pharm Sci. 2010 Sep;72(5):576-81. doi: 10.4103/0250-474X.78523.
6
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.醋氯芬酸:对其在疼痛和风湿性疾病管理中应用的重新评估
Drugs. 2001;61(9):1351-78. doi: 10.2165/00003495-200161090-00012.
7
Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis.在骨关节炎治疗中,醋氯芬酸是一种耐受性良好的替代萘普生的药物。
Clin Rheumatol. 1997 Jan;16(1):32-8. doi: 10.1007/BF02238760.
8
Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.醋氯芬酸与替诺昔康治疗类风湿关节炎的疗效和安全性比较研究
Clin Rheumatol. 1996 Sep;15(5):473-7. doi: 10.1007/BF02229644.
9
Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.醋氯芬酸治疗类风湿性关节炎:一种有用的新型抗炎药。
Clin Rheumatol. 1996 Jul;15(4):329-34. doi: 10.1007/BF02230353.
10
Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management.醋氯芬酸。对其药效学特性以及在治疗风湿性疾病和疼痛管理方面的治疗潜力的综述。
Drugs. 1996 Jul;52(1):113-24. doi: 10.2165/00003495-199652010-00008.